Sand Hill Global Advisors, LLC Gilead Sciences, Inc. Transaction History

Sand Hill Global Advisors, LLC

$2.11 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $2.13 Million - $2.41 Million	-32,785 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $31,678 - $34,178	-468 Reduced 1.41%	32,785 $2.29 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $100,599 - $109,919	1,585 Added 5.01%	33,253 $2.29 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $131,940 - $150,543	2,199 Added 7.46%	31,668 $2.05 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $661,275 - $753,492	-11,673 Reduced 28.37%	29,469 $1.72 Million

Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $81,972 - $103,065	-1,320 Reduced 3.11%	41,142 $2.6 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $243,062 - $282,240	-3,360 Reduced 7.33%	42,462 $3.27 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $18,287 - $23,424	292 Added 0.64%	45,822 $3.43 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $36.6 Million - $40.2 Million	-593,465 Reduced 92.87%	45,530 $2.96 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $36.9 Million - $40.8 Million	590,739 Added 1224.18%	638,995 $40.5 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $50,795 - $56,960	-821 Reduced 1.67%	48,256 $3.26 Million
Q1 2019 May 03, 2019	SELL	$62.53 - $70.05 $106,050 - $118,804	-1,696 Reduced 3.34%	49,077 $3.19 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $1 Million - $1.31 Million	-16,545 Reduced 24.58%	50,773 $3.18 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $357,255 - $395,547	-5,012 Reduced 6.93%	67,318 $5.2 Million
Q2 2018 Aug 10, 2018	BUY	$64.88 - $75.68 $4.28 Million - $4.99 Million	65,933 Added 1030.69%	72,330 $5.12 Million
Q1 2018 May 10, 2018	SELL	$72.84 - $88.8 $5.07 Million - $6.18 Million	-69,577 Reduced 91.58%	6,397 $482,000
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $13,020 - $15,284	-183 Reduced 0.24%	75,974 $5.44 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $5.49 Million - $6.51 Million	76,157	76,157 $6.17 Million

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

Black Rock Inc. New York, NY

123M
Shares

$8.41 Billion
0.21% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$7.87 Billion
0.17% of portfolio
Capital World Investors Los Angeles, CA

84.5M
Shares

$5.8 Billion
1.06% of portfolio
Capital Research Global Investors Los Angeles, CA

61.2M
Shares

$4.2 Billion
1.05% of portfolio
State Street Corp Boston, MA

57.7M
Shares

$3.96 Billion
0.19% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sand Hill Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sand Hill Global Advisors, LLC with notifications on news.

Account